The board of directors of Pittsburgh-based Longevity Health Holdings, a company focused on longevity and healthy aging, has announced that it is exploring and evaluating strategic alternatives for the bio-aesthetic and therapeutic businesses that will maximize value for the company and its stakeholders.
The decision process will include evaluating multiple options including a merger, reverse merger or other business combination. It also may include a strategic partnership, a sale or license of one or more of the company’s businesses or assets, or another type of transaction.
“With the Puritan Partners litigation settled, now is the right time to take a disciplined look at every path available to the Company,” Ram Ajjarapu, Longevity chairman and CEO, said. “We have built a portfolio of regenerative skincare brands in addition to our bone and tissue healing therapeutic products whose further development has been on pause, and the Board is committed to pursuing the path that best serves the Company and its stakeholders.”
The company has not set a timetable to make a decision and doesn’t plan to announce any updates unless the board approves a specific transaction or determines that disclosure is appropriate or required.
Longevity Health Holdings works to advance regenerative bio-aesthetics.